X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (77) 77
middle aged (60) 60
adult (54) 54
index medicus (52) 52
female (50) 50
male (46) 46
hematology (43) 43
aged (38) 38
oncology (31) 31
adolescent (28) 28
prognosis (26) 26
treatment outcome (24) 24
leukemia, myeloid, acute - genetics (21) 21
leukemia, myeloid, acute - mortality (20) 20
aml (19) 19
survival analysis (19) 19
chemotherapy (18) 18
leukemia, myeloid, acute - drug therapy (18) 18
acute myelogenous leukemia (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
mutation (17) 17
aged, 80 and over (16) 16
cancer (16) 16
young adult (16) 16
acute myeloid leukemia (15) 15
disease-free survival (15) 15
recurrence (15) 15
remission induction (14) 14
transplantation (14) 14
acute disease (13) 13
acute myeloid-leukemia (13) 13
transplantation, homologous (13) 13
leukemia, myeloid, acute - therapy (12) 12
analysis (11) 11
hematopoietic stem cell transplantation (11) 11
leukemia, myeloid - genetics (11) 11
nuclear proteins - genetics (11) 11
electricity (10) 10
fms-like tyrosine kinase 3 - genetics (10) 10
leukemia (10) 10
leukemia, myeloid, acute - pathology (10) 10
prospective studies (10) 10
mutations (9) 9
stem-cell transplantation (9) 9
survival (9) 9
therapy (9) 9
cytarabine - administration & dosage (8) 8
hematopoietic stem cells (8) 8
p-glycoprotein (8) 8
retrospective studies (8) 8
risk (8) 8
antennas, i.e. radio aerials (7) 7
basic electric elements (7) 7
cytarabine - therapeutic use (7) 7
favorable prognosis (7) 7
hematology, oncology and palliative medicine (7) 7
high-dose cytarabine (7) 7
internal tandem duplication (7) 7
myelodysplastic syndrome (7) 7
normal karyotype (7) 7
survival rate (7) 7
abridged index medicus (6) 6
adult patients (6) 6
antineoplastic agents - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
blasting (6) 6
chromosome aberrations (6) 6
cohort studies (6) 6
combined heating and refrigeration systems (6) 6
cytogenetics (6) 6
environmental sciences (6) 6
gene expression (6) 6
heat pump systems (6) 6
heat-pump systems (6) 6
heating (6) 6
immunology (6) 6
leukemia, myeloid - drug therapy (6) 6
lighting (6) 6
liquefaction solidification of gases (6) 6
manufacture or storage of ice (6) 6
mechanical engineering (6) 6
normal cytogenetics (6) 6
older patients (6) 6
positive displacement machines for liquids (6) 6
pumps (6) 6
pumps for liquids or elastic fluids (6) 6
recommendations (6) 6
refrigeration machines, plants or systems (6) 6
refrigeration or cooling (6) 6
relapse (6) 6
research (6) 6
stem cell transplantation (6) 6
transmission (6) 6
weapons (6) 6
younger adults (6) 6
age factors (5) 5
antimetabolites, antineoplastic - therapeutic use (5) 5
care and treatment (5) 5
clinical trials (5) 5
clinical-significance (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9850, pp. 1309 - 1316
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2000 - 2008
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2493 - 2498
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 25, pp. 3110 - 3118
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 676 - 683
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2012, Volume 30, Issue 29, pp. 3604 - 3610
Journal Article
Blood, ISSN 0006-4971, 12/2012, Volume 120, Issue 26, pp. 5185 - 5187
Journal Article
14.